# DOXEPIN HYDROCHLORIDE
> **ANDA215408** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS · Approved 2023-02-17
## Drug
- **FDA Application Number:** ANDA215408
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOXEPIN HYDROCHLORIDE
- **Generic name:** DOXEPIN HYDROCHLORIDE
- **Active ingredients:** DOXEPIN HYDROCHLORIDE
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS
- **Manufacturer:** Teva Pharmaceuticals USA, Inc.
- **First approval:** 2023-02-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215408)
---
*MORVS · CC0 1.0*